Our team at Millendo is relentlessly pursuing therapies that alleviate patient suffering due to endocrine diseases.
A message for Prader-Willi syndrome patients and families learn more.

Our Story

Who we are
and what we do

Our Patients

Engaging with empathy to focus on our patients

Our Science

Building our clinical pipeline

Join Our Team

Discover how “Millendoers” are making things happen and how you can join us

Millendo in the News

May 8, 2020
Millendo Therapeutics Reports First Quarter 2020 Operating and Financial Results
April 6, 2020
Millendo Therapeutics Announces Topline Results for Pivotal Phase 2b Study of Livoletide in Patients with Prader-Willi Syndrome (PWS)
March 11, 2020
Millendo Therapeutics Reports Full Year 2019 Operating and Financial Results

US Offices

Corporate Headquarters

110 Miller Avenue, Suite 100
Ann Arbor, MI 48104

Lexington Office

420 Bedford Street,
Suite 260
Lexington, MA 02420

Europe Office

Lyon Office

Millendo Therapeutics SAS
c/o Canopee consulting
8 rue Berjon
69009 Lyon
Tel +33 472 18 94 28

Scroll to Top